Archives
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Rapakinin Reveals a PGI₂–IP–CCK1 Vasorelaxation Pathway
2026-10-01
The reference study shows that rapakinin, the Arg-Ile-Tyr peptide from rapeseed protein, relaxes mesenteric arteries from spontaneously hypertensive rats through a prostaglandin I₂–IP receptor pathway that signals downstream to CCK1 receptors. Its weak dependence on nitric oxide synthase and bradykinin B2 signaling reframes how peptide-derived antihypertensive activity can be investigated in vascular tone regulation studies.
-
ATG4B Nuclear Translocation Links Energy Deficiency to AML
2026-10-01
The reference study identifies an energy-sensitive mechanism in which nuclear translocation of ATG4B disrupts PRMT1-dependent MRE11 methylation, weakening DNA repair and accelerating acute myeloid leukemia progression. Its combination of mechanistic studies, patient-derived AML models, genetically induced leukemia, and xenograft experiments positions ATG4B inhibition as a preclinical strategy for reducing genomic instability.
-
Betaine hydrochloride in Inflammation Assays
2026-09-30
Betaine hydrochloride provides a water-soluble, tunable matrix variable for enzyme, protease, cell-based, and inflammation-linked assays. This workflow separates what the reagent can control experimentally from the anti-inflammatory activity reported for oridonin, helping researchers build cleaner mechanistic comparisons.
-
Cy5-UTP for RNA Labeling and R-Loop Imaging
2026-09-30
Cy5-UTP enables direct far-red visualization of RNA generated by T7 transcription, supporting FISH, expression-array, and single-molecule assays. This guide translates its labeling chemistry into practical workflows for studying RNA–DNA hybrids and replication conflicts while highlighting controls, optimization points, and limitations.
-
ATRX-Deficient Glioma Sensitivity to RTK Inhibitors
2026-09-29
The reference study identifies a genotype-linked vulnerability in high-grade glioma: ATRX-deficient cells show increased sensitivity to multi-targeted receptor tyrosine kinase and PDGFR inhibitors. Its drug-screening and temozolomide combination data support ATRX status as a potentially useful stratification variable for interpreting RTK inhibitor studies, while remaining preclinical.
-
Patient-Derived Gastric Cancer Assembloids
2026-09-29
This 2025 study develops patient-derived gastric cancer assembloids by combining matched tumor organoids with tumor-derived stromal subpopulations. The model reveals that stromal composition reshapes gene expression and drug sensitivity, providing a more physiologically relevant platform for resistance studies and personalized therapeutic screening.
-
Trilaurin: Solubility, QC, and Workflow Setup
2026-09-28
Trilaurin, also called Glycerol Tridodecanoate, is a defined C12 triacylglycerol for lipid formulation development and enzyme-substrate workflows, with practical solubility options in DMSO and ethanol. It should not be treated as water-soluble or as evidence of biological efficacy; formulation, animal-study, cosmetic, and biocatalytic applications require application-specific validation.
-
Fiber Density Rebuilds Annulus Fibrosus Matrix Patterns
2026-09-28
This study shows that changing the fiber density of composition-matched electrospun scaffolds can shift annulus fibrosus cells toward distinct collagen-producing phenotypes. Its findings connect scaffold microarchitecture with mechanotransduction and suggest a design strategy for recreating, rather than merely closing, the annulus fibrosus defect.
-
Galectin-1–FIP200 Signaling in Hepatic Steatosis
2026-09-27
The study identifies a direct interaction between galectin-1 and FIP200 as a mechanism that suppresses autophagy and promotes hepatic steatosis, dyslipidemia, and insulin resistance. Its combination of mouse overexpression, proteomic profiling, binding analysis, and interaction-disrupting mutations provides a framework for testing how autophagy control contributes to metabolic liver disease.
-
BTK Inhibition: From Mechanism to Translation
2026-09-26
Explore how PCI-32765 enables rigorous BTK pathway studies, from B-cell receptor signaling and CLL models to translationally grounded experimental design.
-
α-Bungarotoxin for Cholinergic Blockade Research
2026-09-25
Use α-Bungarotoxin to test whether α7 nicotinic receptor signaling is necessary for a cellular or tissue response—not merely associated with it. A recent placental ischemia study illustrates this antagonist-based strategy, while the workflow below adapts it for carefully controlled cell assays and neuroscience research.
-
Hepatocyte Arrb2 and 6-ketoLCA in Liver IRI
2026-09-25
This study identifies hepatocyte Arrb2 as a regulator of a metabolite-linked interaction between liver cells and macrophages during ischemia–reperfusion injury. Its findings support a protective pathway involving 6-ketoLCA and M2 macrophage polarization, while leaving important questions about the pathway’s molecular details and clinical translation open.
-
Lipo3K Transfection Reagent for Viability Assays
2026-09-24
Learn how Lipo3K Transfection Reagent (SKU K2705) can support nucleic-acid delivery in viability, proliferation, and cytotoxicity workflows. This scenario-led guide covers assay controls, timing, co-transfection, interpretation, and practical product selection.
-
T0070907 and PPARγ: Testing a Foam-Cell Pathway
2026-09-24
A mechanistic look at how T0070907 can help translational teams test whether PPARγ activity is required for the RXRα/PPARγ/NEDD4 response reported in atherosclerosis research—without confusing pathway probing with therapeutic proof.
-
Tioconazole Workflows for Antifungal Research
2026-09-23
Build more interpretable Tioconazole experiments by pairing dose-response testing with solvent-matched controls and an orthogonal viability readout. This guide connects its ergosterol-targeting rationale to practical in vitro workflows while clearly separating antifungal evidence from an unrelated leukemia study used only as a lesson in experimental context.